Reax

Biotheryx

The company develops protein degrader medicines for patients with cancer and inflammatory diseases.

Vividion

The company develops small-molecule medicines for patients with cancer and immune disorders using a proprietary chemoproteomics platform to target previously undruggable proteins.

Rezo Therapeutics

This biotechnology company develops drug discovery platforms and targeted therapies for oncology and other serious diseases, serving the pharmaceutical and healthcare industries.

Jnana Therapeutics

This clinical-stage biotechnology company develops small molecule medicines for patients with rare and immune-mediated diseases using a proprietary chemoproteomics drug discovery platform.

Plexium

This company develops targeted protein degradation therapeutics and discovery platforms for patients with cancer and neurodegenerative diseases.

Biopharmaceutical company

This firm develops small molecule drugs targeting protein regulatory sites to treat patients with cancer and autoimmune diseases.

Enodia

This company develops small-molecule therapies that degrade disease-causing proteins at the point of synthesis for patients with cancer and inflammatory diseases.

OMass Therapeutics

This company develops small molecule therapeutics for patients with immunological and rare diseases using a proprietary native mass spectrometry platform.